Effect of Body Composition and Renal Function on the Pharmacokinetics of High-Dose Melphalan for Multiple Myeloma by Vogl, D.T, Mick, R, Stoopler, E, Davis, L.E, Paul, T.M, Salazar, G, Raguza-Lopez, M, Porter, D.L, Luger, S.M, Stadtmauer, E.A

Get full text

Feasibility, Safety and Efficacy of Maraviroc, a CCR5 Antagonist, in Graft-Versus-Host Disease Prevention After Reduced intensity Conditioned (RIC) Allogeneic Stem Cell Transplant... by Reshef, R, Luger, S.M, Loren, A.W, Frey, N.V, Goldstein, S.C, Hexner, E.O, Stadtmauer, E.A, Smith, J, Mick, R, Heitjan, D.F, Hoxie, J.A, Emerson, S.G, Vonderheide, R.H, Porter, D.L

Get full text

Pegfilgrastim versus filgrastim to accelerate hematopoietic recovery after high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma by Olin, R.L., Luger, S.M., Porter, D.L., Schuster, S.J., Tsai, D., Nasta, S., Perl, A., Loren, A.W., Goldstein, S., Mangan, P., Sherry, V., Cunningham, K., Sachs, B., Hummel, K., Stadtmauer, E.A.

Get full text

Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity by Tobler, K, Freudenthaler, A, Baumgartner-Parzer, S.M, Wolzt, M, Ludvik, B, Nansalmaa, E, Nowotny, P.J, Seidinger, D, Steiner, S, Luger, A, Artwohl, M

Get full text